{"nct_id":"NCT04521231","title":"A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2021-01-04","start_date_type":"ACTUAL","primary_completion_date":"2027-12-24","primary_completion_date_type":"ESTIMATED","completion_date":"2029-05-25","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["AMGN"]}